nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.236	0.326	CbGaD
Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.176	0.244	CbGaD
Imipramine—DRD2—attention deficit hyperactivity disorder	0.175	0.243	CbGaD
Imipramine—HTR2A—attention deficit hyperactivity disorder	0.136	0.187	CbGaD
Imipramine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00517	0.0566	CbGeAlD
Imipramine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00498	0.0546	CbGeAlD
Imipramine—ORM1—saliva—attention deficit hyperactivity disorder	0.00358	0.0392	CbGeAlD
Imipramine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00311	0.034	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00275	0.0301	CbGeAlD
Imipramine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00265	0.029	CbGeAlD
Imipramine—KCND2—forebrain—attention deficit hyperactivity disorder	0.00179	0.0196	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00165	0.0181	CbGeAlD
Imipramine—KCND3—forebrain—attention deficit hyperactivity disorder	0.00156	0.0171	CbGeAlD
Imipramine—KCND2—cardiovascular system—attention deficit hyperactivity disorder	0.00151	0.0165	CbGeAlD
Imipramine—HTR6—forebrain—attention deficit hyperactivity disorder	0.00133	0.0145	CbGeAlD
Imipramine—KCND3—cardiovascular system—attention deficit hyperactivity disorder	0.00132	0.0144	CbGeAlD
Imipramine—KCND2—midbrain—attention deficit hyperactivity disorder	0.00118	0.0129	CbGeAlD
Imipramine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00104	0.0114	CbGeAlD
Imipramine—KCND3—midbrain—attention deficit hyperactivity disorder	0.00103	0.0113	CbGeAlD
Imipramine—KCND2—nervous system—attention deficit hyperactivity disorder	0.00097	0.0106	CbGeAlD
Imipramine—KCND2—central nervous system—attention deficit hyperactivity disorder	0.000933	0.0102	CbGeAlD
Imipramine—KCND2—cerebellum—attention deficit hyperactivity disorder	0.000912	0.00999	CbGeAlD
Imipramine—KCND3—nervous system—attention deficit hyperactivity disorder	0.000845	0.00926	CbGeAlD
Imipramine—KCND3—central nervous system—attention deficit hyperactivity disorder	0.000814	0.00892	CbGeAlD
Imipramine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.000805	0.00882	CbGeAlD
Imipramine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.000796	0.00872	CbGeAlD
Imipramine—KCND3—cerebellum—attention deficit hyperactivity disorder	0.000795	0.00871	CbGeAlD
Imipramine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.000794	0.00869	CbGeAlD
Imipramine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000782	0.00856	CbGeAlD
Imipramine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000775	0.00849	CbGeAlD
Imipramine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000767	0.0084	CbGeAlD
Imipramine—KCND2—brain—attention deficit hyperactivity disorder	0.000741	0.00812	CbGeAlD
Imipramine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000727	0.00797	CbGeAlD
Imipramine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000724	0.00794	CbGeAlD
Imipramine—HTR6—nervous system—attention deficit hyperactivity disorder	0.000721	0.00789	CbGeAlD
Imipramine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000694	0.0076	CbGeAlD
Imipramine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000673	0.00737	CbGeAlD
Imipramine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000648	0.0071	CbGeAlD
Imipramine—KCND3—brain—attention deficit hyperactivity disorder	0.000646	0.00708	CbGeAlD
Imipramine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000646	0.00707	CbGeAlD
Imipramine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00064	0.00701	CbGeAlD
Imipramine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000629	0.00689	CbGeAlD
Imipramine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000617	0.00676	CbGeAlD
Imipramine—CHRM4—brain—attention deficit hyperactivity disorder	0.000615	0.00674	CbGeAlD
Imipramine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000613	0.00671	CbGeAlD
Imipramine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000606	0.00664	CbGeAlD
Imipramine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000595	0.00652	CbGeAlD
Imipramine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000583	0.00639	CbGeAlD
Imipramine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000575	0.0063	CbGeAlD
Imipramine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.000575	0.0063	CbGeAlD
Imipramine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000563	0.00616	CbGeAlD
Imipramine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000554	0.00607	CbGeAlD
Imipramine—HTR6—brain—attention deficit hyperactivity disorder	0.000551	0.00603	CbGeAlD
Imipramine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000546	0.00598	CbGeAlD
Imipramine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000542	0.00593	CbGeAlD
Imipramine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000524	0.00574	CbGeAlD
Imipramine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000522	0.00572	CbGeAlD
Imipramine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000507	0.00555	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000503	0.00551	CbGeAlD
Imipramine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000486	0.00532	CbGeAlD
Imipramine—CHRM5—brain—attention deficit hyperactivity disorder	0.000481	0.00527	CbGeAlD
Imipramine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00048	0.00526	CbGeAlD
Imipramine—ORM1—nervous system—attention deficit hyperactivity disorder	0.000463	0.00508	CbGeAlD
Imipramine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000461	0.00505	CbGeAlD
Imipramine—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000446	0.00489	CbGeAlD
Imipramine—ADRA1B—brain—attention deficit hyperactivity disorder	0.00044	0.00482	CbGeAlD
Imipramine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000432	0.00473	CbGeAlD
Imipramine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000431	0.00472	CbGeAlD
Imipramine—ADRA1D—brain—attention deficit hyperactivity disorder	0.00043	0.00471	CbGeAlD
Imipramine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000426	0.00467	CbGeAlD
Imipramine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000424	0.00465	CbGeAlD
Imipramine—SLC22A4—cerebellum—attention deficit hyperactivity disorder	0.000419	0.00459	CbGeAlD
Imipramine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000416	0.00456	CbGeAlD
Imipramine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000416	0.00456	CbGeAlD
Imipramine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000415	0.00454	CbGeAlD
Imipramine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000409	0.00448	CbGeAlD
Imipramine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000407	0.00446	CbGeAlD
Imipramine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000406	0.00444	CbGeAlD
Imipramine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000405	0.00444	CbGeAlD
Imipramine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000401	0.00439	CbGeAlD
Imipramine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000399	0.00437	CbGeAlD
Imipramine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000395	0.00432	CbGeAlD
Imipramine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000393	0.00431	CbGeAlD
Imipramine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.00039	0.00428	CbGeAlD
Imipramine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000385	0.00422	CbGeAlD
Imipramine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000385	0.00422	CbGeAlD
Imipramine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.00038	0.00416	CbGeAlD
Imipramine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00038	0.00416	CbGeAlD
Imipramine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000379	0.00415	CbGeAlD
Imipramine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000374	0.0041	CbGeAlD
Imipramine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000352	0.00386	CbGeAlD
Imipramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000351	0.00384	CbGeAlD
Imipramine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.00035	0.00384	CbGeAlD
Imipramine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000348	0.00381	CbGeAlD
Imipramine—SLC22A4—brain—attention deficit hyperactivity disorder	0.000341	0.00373	CbGeAlD
Imipramine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.000339	0.00371	CbGeAlD
Imipramine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000337	0.0037	CbGeAlD
Imipramine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000335	0.00367	CbGeAlD
Imipramine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000335	0.00367	CbGeAlD
Imipramine—CHRM2—brain—attention deficit hyperactivity disorder	0.00033	0.00362	CbGeAlD
Imipramine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00033	0.00361	CbGeAlD
Imipramine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000329	0.00361	CbGeAlD
Imipramine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000325	0.00356	CbGeAlD
Imipramine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000324	0.00355	CbGeAlD
Imipramine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000323	0.00354	CbGeAlD
Imipramine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000322	0.00353	CbGeAlD
Imipramine—HTR2C—brain—attention deficit hyperactivity disorder	0.000318	0.00349	CbGeAlD
Imipramine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000317	0.00347	CbGeAlD
Imipramine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000315	0.00345	CbGeAlD
Imipramine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000312	0.00342	CbGeAlD
Imipramine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000311	0.00341	CbGeAlD
Imipramine—SLC22A3—brain—attention deficit hyperactivity disorder	0.00031	0.0034	CbGeAlD
Imipramine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000305	0.00334	CbGeAlD
Imipramine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000304	0.00333	CbGeAlD
Imipramine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000302	0.00331	CbGeAlD
Imipramine—CHRM1—brain—attention deficit hyperactivity disorder	0.000301	0.00329	CbGeAlD
Imipramine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.0003	0.00329	CbGeAlD
Imipramine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000298	0.00326	CbGeAlD
Imipramine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000294	0.0362	CrCbGaD
Imipramine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000294	0.00322	CbGeAlD
Imipramine—CHRM3—brain—attention deficit hyperactivity disorder	0.000269	0.00295	CbGeAlD
Imipramine—HTR1A—brain—attention deficit hyperactivity disorder	0.000268	0.00293	CbGeAlD
Imipramine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000266	0.00291	CbGeAlD
Imipramine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000257	0.0315	CrCbGaD
Imipramine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000256	0.00281	CbGeAlD
Imipramine—HTR7—brain—attention deficit hyperactivity disorder	0.000256	0.0028	CbGeAlD
Imipramine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000254	0.00278	CbGeAlD
Imipramine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000252	0.00276	CbGeAlD
Imipramine—HRH1—nervous system—attention deficit hyperactivity disorder	0.00025	0.00274	CbGeAlD
Imipramine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000247	0.00271	CbGeAlD
Imipramine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000247	0.0027	CbGeAlD
Imipramine—DRD2—brain—attention deficit hyperactivity disorder	0.000242	0.00265	CbGeAlD
Imipramine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.0298	CrCbGaD
Imipramine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000241	0.00264	CbGeAlD
Imipramine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00024	0.00263	CbGeAlD
Imipramine—KCNH2—brain—attention deficit hyperactivity disorder	0.000239	0.00261	CbGeAlD
Imipramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000236	0.029	CrCbGaD
Imipramine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000231	0.00253	CbGeAlD
Imipramine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000226	0.00248	CbGeAlD
Imipramine—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.0267	CrCbGaD
Imipramine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000213	0.00234	CbGeAlD
Imipramine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000209	0.00229	CbGeAlD
Imipramine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000201	0.0022	CbGeAlD
Imipramine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000197	0.00215	CbGeAlD
Imipramine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000196	0.00214	CbGeAlD
Imipramine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000196	0.0241	CrCbGaD
Imipramine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000193	0.00212	CbGeAlD
Imipramine—HRH1—brain—attention deficit hyperactivity disorder	0.000191	0.00209	CbGeAlD
Imipramine—Maprotiline—SLC6A3—attention deficit hyperactivity disorder	0.000191	0.0234	CrCbGaD
Imipramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00019	0.00208	CbGeAlD
Imipramine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000186	0.00204	CbGeAlD
Imipramine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000184	0.00201	CbGeAlD
Imipramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000183	0.00201	CbGeAlD
Imipramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000179	0.00196	CbGeAlD
Imipramine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000176	0.0216	CrCbGaD
Imipramine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000167	0.00182	CbGeAlD
Imipramine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000163	0.02	CrCbGaD
Imipramine—HTR2A—brain—attention deficit hyperactivity disorder	0.00016	0.00175	CbGeAlD
Imipramine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000159	0.0195	CrCbGaD
Imipramine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000156	0.0192	CrCbGaD
Imipramine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000152	0.0187	CrCbGaD
Imipramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000145	0.00159	CbGeAlD
Imipramine—Maprotiline—DRD2—attention deficit hyperactivity disorder	0.000142	0.0174	CrCbGaD
Imipramine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000138	0.0169	CrCbGaD
Imipramine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.000138	0.0169	CrCbGaD
Imipramine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000137	0.0015	CbGeAlD
Imipramine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000132	0.00144	CbGeAlD
Imipramine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000131	0.0161	CrCbGaD
Imipramine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000129	0.00141	CbGeAlD
Imipramine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000128	0.0158	CrCbGaD
Imipramine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.0157	CrCbGaD
Imipramine—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000127	0.0156	CrCbGaD
Imipramine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.0154	CrCbGaD
Imipramine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000124	0.0152	CrCbGaD
Imipramine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000115	0.0141	CrCbGaD
Imipramine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000115	0.0141	CrCbGaD
Imipramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000114	0.014	CrCbGaD
Imipramine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000113	0.0139	CrCbGaD
Imipramine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000112	0.0138	CrCbGaD
Imipramine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000111	0.0137	CrCbGaD
Imipramine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.00011	0.0135	CrCbGaD
Imipramine—Maprotiline—HTR2A—attention deficit hyperactivity disorder	0.00011	0.0135	CrCbGaD
Imipramine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000108	0.0132	CrCbGaD
Imipramine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.013	CrCbGaD
Imipramine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000105	0.0129	CrCbGaD
Imipramine—ABCB1—brain—attention deficit hyperactivity disorder	0.000105	0.00115	CbGeAlD
Imipramine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.0127	CrCbGaD
Imipramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.0124	CrCbGaD
Imipramine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.0001	0.0123	CrCbGaD
Imipramine—Promazine—DRD1—attention deficit hyperactivity disorder	9.63e-05	0.0118	CrCbGaD
Imipramine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	9.58e-05	0.0118	CrCbGaD
Imipramine—Mianserin—DRD2—attention deficit hyperactivity disorder	9.53e-05	0.0117	CrCbGaD
Imipramine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	9.42e-05	0.0116	CrCbGaD
Imipramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	8.95e-05	0.011	CrCbGaD
Imipramine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	8.86e-05	0.0109	CrCbGaD
Imipramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	8.79e-05	0.0108	CrCbGaD
Imipramine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	8.76e-05	0.0108	CrCbGaD
Imipramine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	8.66e-05	0.0106	CrCbGaD
Imipramine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	8.63e-05	0.0106	CrCbGaD
Imipramine—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	8.56e-05	0.0105	CrCbGaD
Imipramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	8.54e-05	0.0105	CrCbGaD
Imipramine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	8.52e-05	0.0105	CrCbGaD
Imipramine—Nortriptyline—DRD2—attention deficit hyperactivity disorder	8.51e-05	0.0105	CrCbGaD
Imipramine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	8.48e-05	0.0104	CrCbGaD
Imipramine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	8.06e-05	0.00991	CrCbGaD
Imipramine—Trimipramine—DRD2—attention deficit hyperactivity disorder	8.02e-05	0.00985	CrCbGaD
Imipramine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	7.88e-05	0.00968	CrCbGaD
Imipramine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	7.83e-05	0.00963	CrCbGaD
Imipramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	7.79e-05	0.00957	CrCbGaD
Imipramine—Promethazine—DRD2—attention deficit hyperactivity disorder	7.72e-05	0.00949	CrCbGaD
Imipramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	7.68e-05	0.00944	CrCbGaD
Imipramine—Doxepin—DRD2—attention deficit hyperactivity disorder	7.64e-05	0.00939	CrCbGaD
Imipramine—Mianserin—HTR2A—attention deficit hyperactivity disorder	7.36e-05	0.00905	CrCbGaD
Imipramine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	7.05e-05	0.00866	CrCbGaD
Imipramine—Desipramine—DRD2—attention deficit hyperactivity disorder	7.01e-05	0.00862	CrCbGaD
Imipramine—Promazine—DRD2—attention deficit hyperactivity disorder	6.79e-05	0.00835	CrCbGaD
Imipramine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	6.73e-05	0.00827	CrCbGaD
Imipramine—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	6.58e-05	0.00809	CrCbGaD
Imipramine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	6.19e-05	0.00761	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	6.05e-05	0.00744	CrCbGaD
Imipramine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	5.98e-05	0.00734	CrCbGaD
Imipramine—Promethazine—HTR2A—attention deficit hyperactivity disorder	5.96e-05	0.00733	CrCbGaD
Imipramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	5.94e-05	0.0073	CrCbGaD
Imipramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	5.91e-05	0.00726	CrCbGaD
Imipramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	5.9e-05	0.00726	CrCbGaD
Imipramine—Desipramine—HTR2A—attention deficit hyperactivity disorder	5.42e-05	0.00666	CrCbGaD
Imipramine—Promazine—HTR2A—attention deficit hyperactivity disorder	5.25e-05	0.00645	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	4.62e-05	0.00568	CrCbGaD
Imipramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	4.57e-05	0.00561	CrCbGaD
Imipramine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.33e-05	7.49e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.32e-05	7.43e-05	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.32e-05	7.43e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	7.41e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	7.4e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	7.28e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	7.27e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.29e-05	7.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.29e-05	7.25e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.29e-05	7.25e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.28e-05	7.24e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.28e-05	7.21e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.28e-05	7.21e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.28e-05	7.19e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.28e-05	7.19e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.27e-05	7.18e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.27e-05	7.18e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.27e-05	7.17e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.27e-05	7.14e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.26e-05	7.12e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.26e-05	7.1e-05	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.24e-05	7e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.24e-05	6.99e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.24e-05	6.99e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.24e-05	6.97e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.23e-05	6.93e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.23e-05	6.91e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	6.87e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.21e-05	6.83e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.2e-05	6.78e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.2e-05	6.75e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.2e-05	6.74e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.2e-05	6.73e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	6.7e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.19e-05	6.69e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	6.69e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.18e-05	6.67e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.18e-05	6.63e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.18e-05	6.63e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.17e-05	6.58e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.15e-05	6.5e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.15e-05	6.5e-05	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.15e-05	6.47e-05	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.14e-05	6.44e-05	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	1.14e-05	6.43e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.14e-05	6.42e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.14e-05	6.41e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	6.32e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.12e-05	6.29e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.12e-05	6.28e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.11e-05	6.28e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.11e-05	6.24e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.11e-05	6.24e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.1e-05	6.18e-05	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.09e-05	6.16e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.09e-05	6.14e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.09e-05	6.12e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.08e-05	6.11e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.08e-05	6.11e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.08e-05	6.11e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.08e-05	6.09e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.08e-05	6.06e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.07e-05	6.05e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.07e-05	6.02e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.07e-05	6.01e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.07e-05	6.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.06e-05	5.99e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.06e-05	5.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.06e-05	5.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.05e-05	5.91e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.05e-05	5.89e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	5.88e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	5.85e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.03e-05	5.8e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.03e-05	5.8e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.01e-05	5.71e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.01e-05	5.69e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.01e-05	5.68e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1e-05	5.66e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1e-05	5.63e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.94e-06	5.6e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.92e-06	5.59e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.9e-06	5.58e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.87e-06	5.56e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.84e-06	5.54e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.8e-06	5.52e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.75e-06	5.49e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.73e-06	5.48e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.72e-06	5.48e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.68e-06	5.45e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.57e-06	5.39e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.56e-06	5.39e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.52e-06	5.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.49e-06	5.35e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.45e-06	5.32e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.45e-06	5.32e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.4e-06	5.29e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.34e-06	5.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.32e-06	5.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.29e-06	5.23e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.27e-06	5.22e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.26e-06	5.22e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.17e-06	5.16e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.16e-06	5.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.14e-06	5.15e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.11e-06	5.13e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	9.07e-06	5.11e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.06e-06	5.1e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	9.01e-06	5.08e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9e-06	5.07e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9e-06	5.07e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.99e-06	5.07e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.97e-06	5.05e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.94e-06	5.03e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.85e-06	4.99e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.85e-06	4.99e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.83e-06	4.97e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.82e-06	4.97e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.8e-06	4.96e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.75e-06	4.93e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.68e-06	4.89e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.67e-06	4.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.66e-06	4.88e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.63e-06	4.86e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.61e-06	4.85e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.54e-06	4.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.52e-06	4.8e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.5e-06	4.79e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.44e-06	4.76e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.43e-06	4.75e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.41e-06	4.74e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.4e-06	4.73e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.39e-06	4.73e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.38e-06	4.72e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.38e-06	4.72e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	8.37e-06	4.72e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.37e-06	4.72e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.36e-06	4.71e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.33e-06	4.7e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.33e-06	4.69e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.32e-06	4.69e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.29e-06	4.67e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.26e-06	4.66e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.26e-06	4.65e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.25e-06	4.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.25e-06	4.65e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.23e-06	4.64e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.23e-06	4.64e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.22e-06	4.63e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.19e-06	4.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.17e-06	4.6e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.17e-06	4.6e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.16e-06	4.6e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.14e-06	4.59e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.12e-06	4.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.11e-06	4.57e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.09e-06	4.56e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.09e-06	4.56e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.04e-06	4.53e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.01e-06	4.51e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.99e-06	4.5e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.85e-06	4.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	7.8e-06	4.39e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	7.75e-06	4.36e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	7.7e-06	4.34e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.7e-06	4.34e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.65e-06	4.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.6e-06	4.28e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.59e-06	4.27e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.57e-06	4.27e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.56e-06	4.26e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.54e-06	4.25e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.52e-06	4.24e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.47e-06	4.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.46e-06	4.21e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.44e-06	4.19e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.29e-06	4.11e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.07e-06	3.98e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.04e-06	3.97e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	6.71e-06	3.78e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.69e-06	3.77e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.66e-06	3.75e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	6.57e-06	3.7e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.53e-06	3.68e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.53e-06	3.68e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	6.52e-06	3.67e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.52e-06	3.67e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	6.42e-06	3.61e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.37e-06	3.59e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.22e-06	3.5e-05	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	6.19e-06	3.49e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.16e-06	3.47e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.15e-06	3.47e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.13e-06	3.45e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.96e-06	3.36e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.87e-06	3.31e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.86e-06	3.3e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	5.85e-06	3.3e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.41e-06	3.05e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.31e-06	2.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.3e-06	2.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.28e-06	2.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.23e-06	2.95e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.21e-06	2.94e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.21e-06	2.94e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.07e-06	2.86e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.03e-06	2.84e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.03e-06	2.84e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.03e-06	2.84e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.96e-06	2.8e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.95e-06	2.79e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	4.95e-06	2.79e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	4.91e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.88e-06	2.75e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.66e-06	2.63e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.63e-06	2.61e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.6e-06	2.59e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.41e-06	2.49e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.41e-06	2.48e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.16e-06	2.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.02e-06	2.27e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.99e-06	2.25e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	3.95e-06	2.23e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	3.92e-06	2.21e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	3.89e-06	2.19e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.89e-06	2.19e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.83e-06	2.16e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.8e-06	2.14e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.75e-06	2.11e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.62e-06	2.04e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.34e-06	1.88e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.27e-06	1.84e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.25e-06	1.83e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.11e-06	1.75e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.05e-06	1.72e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.03e-06	1.71e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	2.88e-06	1.62e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.87e-06	1.62e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.82e-06	1.59e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	2.82e-06	1.59e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.81e-06	1.59e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.81e-06	1.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.8e-06	1.58e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.77e-06	1.56e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.76e-06	1.56e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.17e-06	1.23e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.12e-06	1.2e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2e-06	1.13e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.69e-06	9.55e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.31e-06	7.37e-06	CbGpPWpGaD
